International Headache Society. International Classification of Headache Disorders 3rd Edition (ICHD-3). Accessed September 21, 2020. https://ichd-3.org/
Friedman BW. Migraine in the emergency department. Neurol Clin. 2019;37(4):743-752.
Wijeratne T, Kuan WS, Kelly AM, et al.; HEAD Study Group. Migraine in the emergency department. Neuroepidemiology. 2022;56(1):32-40.
American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1-18.
Orr SL, Aubé M, Becker WJ, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35(3):271-284.
Vinson DR, Hurtado TR, Vandenberg JT, et al. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med. 2003;41(1):90-97.
Friedman BW, West J, Vinson DR, et al. Current management of migraine in US emergency departments. Cephalalgia. 2015;35(4):301-309.
Yang S, Orlova Y, Lipe A, et al. Trends in the management of headache disorders in US emergency departments. J Clin Med. 2022;11(5):1401.
Ducharme J, Beveridge RC, Lee JS, et al. Emergency management of migraine: is the headache really over? Acad Emerg Med. 1998;5(9):899-905.
Friedman BW, Solorzano C, Esses D, et al. Treating headache recurrence after emergency department discharge. Ann Emerg Med. 2010;56(1):7-17.
Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for acute severe migraine headache. BMJ. 2008;336(7657):1359-1361.
Schellenberg ES, Dryden DM, Pasichnyk D, et al.; Agency for Healthcare Research and Quality. Acute migraine treatment in emergency settings. Comparative effectiveness review no 84. November 2012. Accessed July 21, 2025. https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research.pdf
Rice JB, White AG, Scarpati LM, et al. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216-2229.
Colman I, Brown MD, Innes GD, et al. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Ann Emerg Med. 2005;45(4):393-401.
Colman I, Brown MD, Innes GD, et al. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ. 2004;329(7479):1369-1373.
Friedman BW, Kapoor A, Friedman MS, et al. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med. 2008;52(6):705-713.
Taggart E, Doran S, Kokotillo A, et al. Ketorolac in the treatment of acute migraine: a systematic review. Headache. 2013;53(2):277-287.
Chaimani A, Caldwell DM, Li T, et al. Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al., eds. Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane; 2024. Accessed August 2025. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-11
Watt J, Tricco AC, Straus S, et al. Research techniques made simple: network meta-analysis. J Invest Dermatol. 2019;139(1):4-12.e1.
Kirkland S, Meyer J, Visser L, et al. The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: a systematic review and network analysis. Headache. 2024;64(10):1181-1199.
Loder E, Weizenbaum E, Frishberg B, et al.; American Headache Society Choosing Wisely Task Force. Choosing Wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache. 2013;53(10):1651-1659.
Worthington I, Pringsheim T, Gawel MJ, et al.; Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013;40(5 suppl 3):S1-S80.
